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Abstract
Despite the evident success of using a multivalent approach to increase efficacy of targeted
delivery, a clear understanding of how multiple ligands behave collectively to influence the uptake
of nanoparticle cell-targeting agents has not been reached. Although when present in large
quantity, multivalent ligands can increase binding avidities to cells, it is also conceivable, that the
manner in which these ligands are presented to the cell may have a significant effect on uptake.
Here we examine this parameter using a linear dendritic polymer construct that enabled us to
pattern the surfaces of nanoparticles with variable sized ligand clusters in different spatial
arrangements. We demonstrate for the first time the clear impact of folate presentation on
intracellular uptake both in vitro and in vivo. The findings presented here suggest that the nature
of ligand presentation on a nanoparticle surface may play an important role in drug targeting; the
results suggest potential impact for other targeting moieties and provide a framework for further
refinement of future multivalent targeting strategies.
Many biological systems interact through multiple simultaneous interactions[1–3]. While it is
well acknowledged that, on the macroscale, these multivalent interactions strongly influence
ligand-receptor binding kinetics and the biological responses they govern, the microscale
patterning of ligands on substrates can also have a profound effect on multivalent kinetics
and are able to further modulate biological signaling[4]. In particular, ligand-receptor
clusters can dramatically increase interactions between cell and substrate; not only the
valency, but spatial factors such as branching mode and the localized clustering of groups
are important[5–7] in influencing binding and downstream signaling processes[8, 9]. Still,
despite the prevalence of patterned ligand presentation in cell biology and its demonstrated
significance on 2D tissue engineering formats[10, 11], it remains largely unappreciated by
those who design nanoparticle synthetic systems intended to interact with cells.
Traditionally, ligands have been attached in moderate to large quantities to liposomes,
inorganic nanoparticles and linear-linear block copolymer micelles[12, 13]; however,
typically they are presented in a randomly distributed fashion across the nanoparticle surface
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from a linear tether, typically polyethylene glycol (PEG), in a structure that does not enable
manipulation of ligands in specific groupings with control of cluster group size and spacing.
We hypothesized that precise control over the elements promoting and controlling
multivalent presentation on targeted therapeutic carriers could enhance the efficacy and
specificity of targeted delivery. To test this hypothesis, scaffolds that are able to localize a
variable number of ligands within confined regions are required; this requirement cannot be
satisfied by traditional material systems used in targeted delivery[14] such as linear-linear
block polymers and PEG-functional liposomes. Here we introduce the use of a systematic
and informed linear dendritic design for a new modular polymer delivery system that can
generate clustered or patchy presentations of ligand on micellar surfaces[15]. We
demonstrate the use of pre-functionalized linear dendritic polymers (LDPs) in forming
mixed micelle formulations that present different spatial arrangements of variable sized
ligand clusters and examine the targeting efficacy of these formulations in vitro and in vivo.
The design of the LDP is based on drug delivery principles, and each component is either
fully biodegradable or biocompatible (Figure 1a). Hydrophobic PBLA (poly-benzyl-L-
aspartate) forms the polypeptide linear block to which a generation four hydrolytically
degradable polyester dendron is attached. The sixteen end branches of the dendron are
extended with sixteen short hydrophilic PEG chains. The well-characterized model ligand
folate[16], which is conjugated to the free PEG end via NCC/NHS chemistries, was selected
for this study. A range of folate functionalization on the dendron was confirmed by
both 1HNMR and UV-Vis, which allows the expression of different folate cluster size
ranges on the micelle surface (Figure 2a, Supplemental Figure 1, 2a, 2c). The ability of the
LDP system to form mixed micelles was confirmed by TEM and FRET, and this
information is given in the supplementary information (Supplemental Figure 2d). TEM
analysis using Fe3+ in the place of folate allow visualization of groupings of `ligands' on the
surface of the micelle (Figure 2b).
To investigate the influence of ligand clustering on receptor mediated uptake, a series of
eight micelle formulations were used: 0%F-100%mix, the untargeted control containing
unfunctionalized LDP (0%F) used as 100% of the micelle and 10%F-100%mix,
20%F-60%mix, 30%F-40%mix, 40%F-30%mix, 60%F-20%, 70%F-20%mix and
100%F-10%mix are formulations presenting a similar amount of folate in total. UV-Vis data
show statistically similar numbers of folate per micelle by one way ANOVA analysis
between the different groups at the 95% confidence interval (Figure 2c). We used FR
overexpressing KB cells to evaluate targeting and binding of the micelles to receptors on the
cell surface. After a 24 h period of incubation, the highest cell associated fluorescence was
observed for cells incubated with the 20%F-60%mix formulation (Figure 3a). The measured
EC50 (concentration producing 50% binding) was observed to be the lowest for the
20%F-60%mix micelle. To facilitate discussion, we approximated the apparent dissociation
constants of the tested micelles (KD) by fitting the experimental data to a 1:1 binding model
for site-specific binding. The apparent micelle KD is given in Table 1. EC50 and KD values
are similar, indicating that there is a direct relationship between binding and the measured
fluorescence. The measured dissociation rate constant (koff) of the different micelles also
show that the optimal 20%F-60%mix formulation had the longest dissociation time (2×10−5
s−1) (Figure 2d, Table 1). To examine the apparent rate of association (Kon) relationship
between the micelles, we used the following equation: kon = koff/KD and found that the
calculated values were not significantly different (less than 1 order of magnitude apart,
Table 1). Confocal analysis and competitive binding experiments confirmed that our
observations for binding and targeting are FR mediated and that the mechanism for
internalization of targeted LDP is dependent on both energy driven endocytosis and the
presence of folate receptors (Supplemental Figure 5).
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To further account for the observed differences in cell targeting, we examined the rate of
change of cell associated fluorescence post incubation with micelles as a measure of the
kinetics of internalization via the folate receptor (Figure 3b). After a 1 h binding time for
internalization, the rate of change in cell-associated fluorescence is not significantly
different for all formulations between 1 h and 6 h, indicating that the actual mechanisms of
folate internalization are not dependent on ligand presentation; however, the relative levels
of cell fluorescence show a strong relationship with their respective binding avidities. All
micelle formulations exhibited saturation uptake kinetics at longer time points, suggesting
an equilibrium between uptake and secretion was reached by 20 h (Supplementary Figure
5c). These observations indicate that the enhanced cell targeting of micelles with optimal
folate cluster presentation is attributed to having more micelles bind for longer residence
times on the cell surface, which increases the chance for endocytosis.
We estimate that the dendritic element of the LDP has a head group area of ~50 to 80 nm2
and the FR is a protein of ~30 kDa that projects a binding area of ~13 nm2 into extra-cellular
space[17]. Examinations of cell membranes that overexpress FR indicate that the FR
molecules exist in nanoscale clusters on lipid rafts, with a majority of those clusters
consisting of 3 or more FR molecules[18–22]. Given the available binding space afforded by
each dendron, the range of folate-FR interactions that can occur is between 0–6,
corresponding to LDP conjugated with up to 40% folate. If we were to treat each dendron as
a binding entity, LDP-10%F (1.5 ± 0.4 folates/dendron) would bind most weakly to FR
clusters and the binding energies of LDP-20%F (3.1 ± 0.9), LDP-30% (5.0 ± 0.9), and
LDP-40%F (6.9 ± 0.9) would be greater. Once past the allowable number of ligand-receptor
binding events (>LDP-50%F, 9.9±1.8 folates/dendron) within the binding space, the
presence of excess ligands clustered in a small binding area would result in steric binding
interference, lowering the binding energy[23].
The cooperativity of this multivalent system can also be helpful in understanding binding
effects. The LDP polymer is a negatively cooperative system, as Kmultivalent <
(Kmonovalent)αN, where K is the dissociation constant, N is the total number of ligands and α
is the degree of cooperativity[8] (Table 1). In negatively cooperative systems, each
successive ligand interaction with a receptor is less favorable than the previous interaction.
The calculated degree of cooperativity shows that all formulations were negatively
cooperative (α < 1 for all formulations), but among the tested micelles, 20%F-60%mix had
the highest α, indicating that it is possible to achieve a particular ligand configuration that
optimizes the use of each ligand, making the system less negatively cooperative (α closer to
1).
To investigate the significance of cluster presentation in vivo, we delivered formulations
0%F-100%mix, 20%F-60%mix, 60%F-20%mix and 70%F-20%mix (blood circulation half
lives ~15–20 h Supplementary Figure 6) to nude mice bearing KB (FR+) and A375 (FR−)
tumors. Figure 4 and Supplemental Figure 7 shows the results from imaging 48 h after
injection of micelles. The highest normalized micelle fluorescence were observed for KB
tumors in mice injected with 20%F-60%mix. Ratios for the untargeted formulations and all
targeted formulations against A375 tumors were found to be within error. To further localize
the micelles within the tumor tissue, flow cytometry analysis was performed on tumor cells
isolated from whole tumors. We note that the similar trend in data for flow cytometry
analysis and 3-D optical imaging show that at the 48 h time point, the majority of the
fluorescence accounted for with tumor imaging were from micelles that have been
internalized into tumor cells via specific (substantial) or non-specific mechanisms
(minimal). The intravenously delivered targeted formulations were able to substantially
internalize in live tumor cells in vivo, resulting in a higher population of cells with a higher
fluorescence. Optimal clustering of folate also played an important role in enhancing
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multivalent folate-FR cluster interactions, with the 20%F-60%mix formulation showing the
highest level of fluorescence amongst targeted formulations (P<0.05 for all analyses
comparing 20%F-60%mix, 60%F-20%mix and 70%F-20%mix).
We have shown that ligand presentation is an important design parameter for increasing the
efficacy of targeted nanoparticles. As discussed previously, the rates of endocytosis do not
appear to be affected by ligand presentation. This finding, together with the observation that
the rates of association (kon) were similar for all formulations, support the conclusion that
the enhanced uptake of optimized formulations are most likely dependent on their higher
avidity and longer residence times on the cell membrane, which leads to a higher chance of
endocytosis. This plays a critical role for in vivo targeting where the percentage of
intravenously delivered nanoparticles that reach tumor sites via EPR (enhanced permeation
and retention) is often less than 10 %ID/g[24], resulting in a low concentration of
nanoparticles in the tumor interstitial made available for uptake by tumor cells. To achieve
substantial levels of therapy, the avidity of the delivered nanoparticle must be high enough
to be able to bind to receptors under such conditions. The results presented here suggests
that a shift in focus in molecularly targeted nanocarriers from ligand density to the specific
manipulation of ligand cluster presentation may have important implications on cell
targeting and can guide the development of more effective targeted delivery systems.
METHODS
Synthesis of LDP and its derivatives
We synthesized the LDP according to published protocols22. n-dodecyl-L-glutamate was
substituted for benzyl-L-aspartic acid (Sigma Aldrich) and the synthesized polymer was
characterized with 1H NMR. Folate and labeling agents were conjugated to the LDP
dendron using N-boc-1,3-diaminopropane (synthesized according to published protocols46)
as an intermediate. Detailed information on the synthesis and characterization of the
polymer and the assembled micelles is provided in the Supplementary Information section
online.
Synthesis of LDP and its derivatives
The LDP used in this study (PBLA12-(Generation 4 dendron)Polyester-PEG(600 g/mol)) has
a theoretical molecular weight of 14144 g/mol. For stiochiometric folate attachment to LDP,
folic acid was activated using DCC/NHS chemistry and this was subsequently reacted with
N-boc-1,3-diaminopropane. The resultant molecule (Folate-1,3-diaminopropane-boc) was
deprotected with excess trifluoroacetic acid (10×) and purified by precipitation in water.
After purification, folate-1,3-diaminopropane-NH2 was reacted in stiochiometric excess
with the amount of functional −COOH groups present on the LDP dendron (EDC/NHS) and
in the presence of triethylamine to achieve folate functionalization of the dendron to varying
percentages. All reactions were done in DMF. After reaction, the polymers were dialyzed in
a 10KMWCO dialysis bag for 2 days before lyophilization to yield the product. We
determined the degree of folate functionalization using UV-Vis (free folic acid as
calibration, adsorption at 290nm) and 1HNMR. We used the following peaks as reference:
for folate, the aminobenzoyl moiety at ~6.5ppm (2H) and for LDP, the combined integration
of 4.13ppm (d, 16H, −CH2O) and 4.24–4.32ppm (m, 24H, −CH2O) corresponding to the
dendritic esters (40H). We chose the dendritic ester peaks as a reference because it is
structurally closer to the position of folate on the molecule; these peaks were also used as a
reference for 1HNMR analysis during the synthesis of the LDP. N-boc-1,3-diaminopropane-
DTPA (Sigma Aldrich) / VT680 (VisEn Medical) were also synthesized using DCC/NHS
chemistry and subsequently deprotected to expose the second primary amine for reaction
with activated (DCC/NHS) carboxyl PEG on the LDP. Alexa Fluor 488/594/ 647
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(Invitrogen) cadaverine were directly labeled on the dendron with EDC/NHS chemistry. The
labeling agents were conjugated at a 1:1 LDP:labeling agent molar ratio. After reaction, the
products were separated with dialysis (10KMWCO) and purified with a Sephadex G-25
column before lyophilization. Labeled LDP were made by conjugating labeling agents to the
dendron of unfunctionalized LDP. A small fixed amount (~5% concentration ratio) of the
appropriate labeling LDP was used during self-assembly with the unfunctionalized and
folate functionalized LDP to allow tracking of these particles (all conjugation schemes
summarized in the methods section). This allows all micelle formulations to be labeled
similarly with the dye. During assembly into nanoparticles, the hydrophobic PBLA linear
block forms the core, which encapsulates hydrophobic drugs, while the hydrophilic dendritic
block forms the shell, presenting folate that targets cell receptors. Self-assembly of these
nanoparticles from pre-functionalized LDP enables variable sized folate clusters to be
presented on the nanoparticle surface.
Micelle preparation and characterization
Folate conjugated LDP and non-functionalized LDP were mixed in different ratios to create
nanoparticles with different folate spatial presentations. The micelles were further labeled
either fluorescently or radioactively by incorporation of a small amount of the synthesized
LDP-labeling agent; this ensures micelles contain on average a similar amount of
fluorescent dye. Micelles containing LDP-DTPA were complexed with 111In (InCl) or Fe3+
(FeCl3) in sodium acetate buffer and were purified from the uncomplexed metal ions using a
PD-10 salt column (GE healthcare). Micelles were self-assembled using a dialysis method:
briefly, the LDP formulations (dissolved in DMF) were placed inside a 10KMWCO dialysis
bag (Pierce Chemical) and dialyzed against DI water under sink conditions. DI water was
replaced frequently for a total dialysis time of ~24 h. After all DMF was removed, the
contents of the dialysis bags were filtered with a 0.2 μm teflon filter before lyophilization
and use. Micelles were characterized using dynamic light scattering (CONTIN fit,
ZetaPALS), TEM and FRET (AF488 and AF594 are donor-acceptor pairs). An excitation
wavelength of 475 nm (AF488 donor excitation) was used and emission was recorded at 630
nm (AF594 acceptor emission). For TEM imaging, micelle solutions were drop-cast onto
carbon coated copper grids without any staining. TEM of these micelles was performed on a
JEOL 2011 high contrast digital TEM operating at 200KV accelerating voltage. The degree
of folate conjugation on LDP was determined using UV-vis spectroscopy (absorption at
290nm). Free folic acid was used to obtain a standard calibration. Folate surface density was
determined using aggregation numbers estimated from LDP (Materials Studio) and micelle
dimensions. Addition of folate increased the diameters of the micelles and micelles with the
same amount of folate have averaged diameters within ±10 % of each another (Figure 2e).
In addition, the zeta potentials of all micelle variations were also constant at ~ −20 ± 5 mV
(Supplementary Figure 3). This suggests that the aggregation numbers of the micelles do not
change significantly, even when different polymer ratios are used in the formation of the
micelles. We estimate that the aggregation numbers are in the order of 103 based on data
from DLS/TEM and calculations of the size of each individual LDP from Materials
Studio®. CMCs measured for all micelles were of the same order of magnitude of 10−8M.
Radiolabeling
Formulations (1mg/mL) containing the LDP-DTPA polymer in PBS were incubated with
200 μCi of 111InCl3 (in 1M sodium acetate buffer) at room temperature for 30 min. The
resulting radiolabelled formulations were purified from free 111In by gel filtration through a
PD-10 column (GE healthcare) using PBS as the eluting phase.
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In vitro experimentation
Human nasopharyngeal carcinoma cells (KB, FR positive)43,47 (ATCC), and human
melanoma cells (A375, FR negative)48 (ATCC), were used in our experiments. Folic acid
free 1640 RPMI media was bought from Invitrogen, supplemented with 10% fetal bovine
serum, 50 units/mL penicillin and 50 units/mL streptomycin. All cells were cultured in this
media for at least 4 days before use. For all experiments, cells were scraped, washed,
counted and plated as necessary in 24 or 96 well plates and allowed to grow to ~70%
confluence. Before use, new media was added following a wash with PBS supplemented
with 0.1% BSA. For determining uptake, micelle formulations (0.5mg/mL, AF647 labeled)
were added for different incubation times. After incubation, the cells were washed with PBS
(×3), trypsinized and re-suspended in PBS (0.1% BSA) for flow cytometry analysis. For
binding avidity experiments, a range of micelle formulations at different concentrations
were incubated with cells on ice for 1 h, washed with cold PBS to remove unbound ligand
and re-suspended in cold PBS for flow cytometry analysis. Polymer concentrations used
were above the CMC of 1×10−8M. The degree of specific binding was determined by
subtracting the amount of non-specific binding (micelle with no ligand) from total binding.
To facilitate analysis, apparent KD values were calculated by fitting experimental data to a
non-linear regression method for a 1:1 single site specific binding model in PRISM (built in
model). For dissociation kinetic experiments, cells were fixed in 4% paraformaldehyde,
washed with PBS (0.1% BSA) and allowed to bind with micelles for 1 h to allow
equilibrium. Following incubation, the cells were centrifuged and re-suspended in fresh
buffer without micelles. This cell suspension was constantly stirred and was sampled at
several time points thereafter to determine remaining cell fluorescence as a measure of the
degree of dissociation of bound micelles. The sampled cells were spun down, washed, lysed
and the resultant AF647 fluorescence from the lysed cells was measured using a
spectrofluorometer. The decay in fluorescence was plotted against time and the experimental
data was fitted to a built-in one phase exponential decay model in PRISM to determine
apparent koff values. As Koff and KD were measured at different temperatures, the
calculated rate of association (Kon) using equation: kon = koff/KD, are also apparent values
and are used to show the Kon relationship between different micelles. All flow cytometry
analyses were performed on an LSRII (BD Biosciences) system.
For confocal microscopy, cells were grown until 50% confluent on chamber slides and
treated with various micelle formulations and transferrin-A488 (when necessary) under
different conditions (AF647 labeled). The cells were then washed repeatedly with PBS,
fixed with 4% paraformaldehyde, permeabilized with cold ethanol, blocked with 0.1% BSA
in PBS and stained with Hoechst (10μg/mL) for 5 min. The fixed cells were then washed
again with PBS and examined with a Delta vision confocal microscope (60X).
In vivo experimentation
All in vivo experimentation was carried out under the supervision of the Division of
Comparative Medicine, Massachusetts Institute of Technology, and in compliance with the
Principles of Laboratory Animal Care of the National Institutes of Health.
Female nude BALB/c mice (3–4 weeks old, Charles River) were fed a folate deficient diet
(Research Diets) for at least a week to achieve plasma folate levels commensurate with
humans. Tumors were induced subcutaneously and bilaterally in the hind flanks with 2×106
KB/A375 cells. Experimentation began when the tumors developed to ~ 100–200 mm3
(<10% body weight, <1cm in any dimension). Tumored mice were then separated into
random groups and given tail vein injections of labeled formulations (10 mg polymer/kg, 1
injection/formulation/mice). Blood circulation half-lives were determined by the decrease in
radioactivity from blood drawn from the saphenous vein with heparinized capillary tubes. 3-
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D fluorescence imaging was performed using an IVIS imaging system and mice to be
imaged were given an injection of AngioSense750 (0.1mL/mice, 5nmol) 24hrs before
imaging. VT680 fluorescence was detected using 675nm/720nm (ex/em) and
AngioSense750 was detected using 745/800 (ex/em). For flow cytometry analyses of tumor
cells, xenograft whole tumors were minced completely with sterile blades before a mixture
of collagenase (II) in RMPI 1640 medium was added (200–250 units of collagenase/mL).
The tumor pieces were allowed to incubate at 37°C for 3– 4 hrs with gentle agitation every
30min. At the end of the incubation, cells were filtered through a 0.45μm nylon mesh,
washed with PBS (X3) and counter stained with propidium iodide (5μM), washed with PBS
and re-suspended. VT680 micelle fluorescence was detected on the LSRII using the APC
Cy7 detector.
Statistical Analysis
All values shown are in mean ± STD unless otherwise specified. Analyses were done by
unpaired Student's t-test and one way ANOVA and considered significant at P<0.05.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Chemical structure and self-assembly of linear dendritic polymers (LDP). a) Detailed
chemical structure of the LDP and illustration of its self-assembly (PBLA= poly(benzyl-L-
aspartic acid), PED=polyester dendron, PEG=poly(ethylene glycol)). b) Labeling LDP used
in our study. Labeling schemes are described in methods. c) Folate conjugated to dendron of
LDP at various percentages. Conjugation chemistry is described in methods.
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Figure 2.
Characterization of LDP mixed micelle system. a) Theoretical vs experimental degree of
conjugation to dendron. Experimental values for UV-Vis were calculated using at least 3
independent sets of measurements (mean±STD) with free folic acid as the
calibration. 1HNMR quantification is described in methods. b) TEM images of
representative formulations are shown. Clusters of DTPA-Fe3+ on the micelle surface show
the formation of mixed micelles. Scale bar = 100 nm. Formulations 10%F-100%mix (1),
20%F-60%mix (2), 30%F-40%mix (3) and 30%F-100%mix (4) are shown. c) Summary of
the eight micelle formulations used in this study. 0%F-100%mix is the untargeted control,
all other formulations present similar amounts (not statistically different by one way
ANOVA analysis at the 95% CI) of folate but in different cluster size and arrangements.
Total number of folate presented per micelle (mean±STD) is calculated based on at least 3
sets of data (UV-Vis) using an approximate micelle aggregation number of 1000 (based on
measured diameters and estimates of LDP unimer dimensions from Materials Studio).
Average micelle diameters and zeta potentials are given in mean±STD of the averages of at
least 10 individual measurements per micelle. Additional information on diameter, zeta
potential information and folate presentation are shown in Supplementary Figure 3 and 2b.
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Figure 3.
In vitro evaluation of patchy micelles on KB (folate receptor, FR+) and A375 (FR−) cells. a)
KB cell associated fluorescence after 24 h of incubation with micelle formulations. Highest
fluorescence was measured from KB cells incubated with 20%F-60%mix formulation
(Supplementary 4a). b) Measured cell associated fluorescence of KB cells at 5 min, 1 h and
6 h post incubation. Increase in cell associated fluorescence between 1 h and 6 h are similar
for all targeted formulations, indicating that rate of endocytosis is unaffected by folate
presentation. c) The binding avidity (KD) measured for targeted formulations show highest
avidity with 20%F-60%mix. d) The measured rate of decrease in micelle fluorescence after
fixed KB cells pre-incubated to equilibrium with micelles was re-suspended in PBS. Non-
linear regression analysis using a one phase exponential decay model gives the apparent
dissociation rate constant of micelles from membrane receptors (koff). Calculated values for
targeted formulations show longest dissociation rate constant with 20%F-60%mix. KD, koff
and kon values are shown in Table 1. All graphs shown are made with measurements on n>3
independent experiments and are given in mean±SEM values. Individual flow cytometry
measurements were averaged out of 10000 events.
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Figure 4.
In vivo evaluation of patchy micelles on nude mice bearing two different tumors (Right
flank: KB, Left flank: A375). a) Fluorescence 3-D optical imaging of tumored nude mice
48h after injection with different formulation micelles. Micelle fluorescence (VT680) from
tumors on both flanks are indicated by the arrows. A side by side comparison of VT680 and
AngioSence750 fluorescence is also shown in Supplementary Figure 7 to allow
identification of the tumors. b) Normalized tumor fluorescence (VivoTag680(VT680)/
AngioSense750(AS750)) of tumors (n = 4) showing the highest in vivo targeting with
20%F-60%mix micelles. Raw fluorescence data is an average of the fluorescence in the
region of interest, given in units of efficiency. Ratios are 0.27±0.11, 0.30±0.06, 0.19±0.06
and 0.28±0.04 for A375 tumors and 0.25±0.04, 1.06±0.27, 0.66±0.11 and 0.38±0.16 for KB
tumors (0%F-100%mix, 20%F-60%mix, 60%F-20%mix and 70%F-20%mix respectively).
c) Average cell associated micelle fluorescence for cells gated in Q1+Q3 (see Supplemental
Figure 7) are 160±16, 185±104, 140±17 and 126±15 for A375 tumors and 175±84,
1153±104, 611±71 and 380±126 for KB tumors (0%F-100%mix, 20%F-60%mix,
60%F-20%mix and 70%F-20%mix respectively). All data is given in mean±SEM.
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Table 1
Apparent KD, kon and koff values for the targeted formulations. KD and koff were determined experimentally
(at least 3 sets of independent data each), Kon was calculated as kon= koff/KD using mean koff and KD values.
Micelle KD (M) Koff (s−1) Kon (M−1s−1)
10%F–100%mix (3.1±0.5) E-09 (1.2±0.3) E-03 3.8E+05
20%F–60%mix (1.7±0.3) E-11 (1.6±0.4) E-05 9.6E+05
30%F–40%mix (4.0±1.2) E-11 (3.0±1.8) E-05 7.4E+05
40%F–30%mix (9.2±1.8) E-11 (8.3±0.3) E-05 9.0E+05
60%F–20%mix (2.3±0.8) E-10 (4.0±1.2) E-04 1.8E+06
70%F–20%mix (1.5±0.8) E-10 (1.2±0.7) E-03 7.4E+05
100%F–10%mix (3.3±0.6) E-09 (9.3±1.9) E-04 2.8E+05
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